These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32982158)

  • 21. Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema.
    Furino C; Niro A; Reibaldi M; Boscia F; Alessio G
    J Ophthalmic Vis Res; 2020; 15(4):524-530. PubMed ID: 33133444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: The European DME Registry Study.
    Rosenblatt A; Udaondo P; Cunha-Vaz J; Sivaprasad S; Bandello F; Lanzetta P; Kodjikian L; Goldstein M; Habot-Wilner Z; Loewenstein A;
    Ophthalmology; 2020 Mar; 127(3):377-393. PubMed ID: 31932090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: six-month outcomes of the UDBASA study.
    Sarao V; Veritti D; Furino C; Giancipoli E; Alessio G; Boscia F; Lanzetta P
    Acta Ophthalmol; 2017 Jun; 95(4):e255-e260. PubMed ID: 28139100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab Injection for Treatment of Non-Proliferative Diabetic Macular Edema: A Prospective, Randomized and Blinded Trial.
    Mishra SK; Sinha S; Chauhan R; Kumar A
    Curr Drug Deliv; 2021; 18(6):825-832. PubMed ID: 33267762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid response to dexamethasone intravitreal implant in diabetic macular edema.
    Lo Giudice G; Avarello A; Campana G; Galan A
    Eur J Ophthalmol; 2018 Jan; 28(1):74-79. PubMed ID: 28708221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Diabetic Macular Edema with Multiple Dexamethasone Intravitreal Implants: Evidence from Real-Life Experience.
    De Geronimo D; Giorno P; Scarinci F; Boninfante A; Varano M; Parravano M
    Ophthalmologica; 2020; 243(6):413-419. PubMed ID: 31760387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema.
    Zucchiatti I; Lattanzio R; Querques G; Querques L; Del Turco C; Cascavilla ML; Bandello F
    Ophthalmologica; 2012; 228(2):117-22. PubMed ID: 22310491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema: A Real-World Experience.
    Mello Filho P; Andrade G; Maia A; Maia M; Biccas Neto L; Muralha Neto A; Moura Brasil O; Minelli E; Dalloul C; Iglicki M
    Ophthalmologica; 2019; 241(1):9-16. PubMed ID: 30408801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Analysis of Intravitreal Dexamethasone Implant (Ozurdex) and Brolucizumab Injection in the Treatment of Diabetic Macular Edema with Hyperreflective Intraretinal Dots: A Retrospective Study.
    Chakraborty S; Sheth JU
    Clin Ophthalmol; 2024; 18():2897-2905. PubMed ID: 39429440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of Intravitreal Dexamethasone Implant Treatment for Diabetic Macular Edema in Vitrectomized Eyes.
    Özdemir HB; Hasanreisoğlu M; Yüksel M; Ertop M; Gürelik G; Özdek Ş
    Turk J Ophthalmol; 2019 Dec; 49(6):323-327. PubMed ID: 31893587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study.
    Lam WC; Albiani DA; Yoganathan P; Chen JC; Kherani A; Maberley DA; Oliver A; Rabinovitch T; Sheidow TG; Tourville E; Wittenberg LA; Sigouin C; Baptiste DC
    Clin Ophthalmol; 2015; 9():1255-68. PubMed ID: 26203215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone Intravitreal Implant for Chronic Diabetic Macular Edema Resistant to Intravitreal Bevacizumab Treatment.
    Totan Y; Güler E; Gürağaç FB
    Curr Eye Res; 2016; 41(1):107-13. PubMed ID: 25610946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of intravitreal dexamethasone implant in patients with cataract and macular edema undergoing phacoemulsification.
    Sze AM; Luk FO; Yip TP; Lee GK; Chan CK
    Eur J Ophthalmol; 2015; 25(2):168-72. PubMed ID: 25363857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
    Boyer DS; Yoon YH; Belfort R; Bandello F; Maturi RK; Augustin AJ; Li XY; Cui H; Hashad Y; Whitcup SM;
    Ophthalmology; 2014 Oct; 121(10):1904-14. PubMed ID: 24907062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial.
    Eter N; Mohr A; Wachtlin J; Feltgen N; Shirlaw A; Leaback R;
    Graefes Arch Clin Exp Ophthalmol; 2017 Jan; 255(1):77-87. PubMed ID: 27460280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up -- the SOLO study.
    Bezatis A; Spital G; Höhn F; Maier M; Clemens CR; Wachtlin J; Lehmann F; Hattenbach LO; Feltgen N; Meyer CH
    Acta Ophthalmol; 2013 Aug; 91(5):e340-7. PubMed ID: 23638803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema.
    Rishi P; Rishi E; Attiku Y; Dhami A; Iyer V
    GMS Ophthalmol Cases; 2020; 10():Doc21. PubMed ID: 32676266
    [No Abstract]   [Full Text] [Related]  

  • 40. [Multicenter Ozurdex® assessment for diabetic macular edema: MOZART study].
    Guigou S; Hajjar C; Parrat E; Merite PY; Pommier S; Matonti F; Prost-Magnin O; Meyer F
    J Fr Ophtalmol; 2014 Jun; 37(6):480-5. PubMed ID: 24813119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.